ClinicalTrials.gg
Not yet recruitingNCT07666919Updated Jun 26, 2026

Pilates for Sedentary Individuals

An interventional study of Pilates exercise and Walking exercise in Sedentary Behaviors and Core Muscle Weakness, sponsored by Mahidol University. Not yet recruiting at 1 site in Thailand. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by Mahidol University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 59 Years
Sex
All
01

Study summary

The global rise in physical inactivity represents an escalating public health crisis, with the proportion of insufficiently active adults projected to reach 35% by 2030. Office workers are at the highest risk due to prolonged occupational sitting; a lifestyle factor heavily linked to various musculoskeletal disorders. While maintaining an upright posture relies on the synergistic coordination of deep core muscles, extended sitting disrupts this muscular balance, leading to chronic postural decay. Although Pilates is proven to improve core muscle thickness, enhance physical fitness, and alleviate low back pain, existing literature shows high variability in training durations (ranging from 6 to 16 weeks) and lacks definitive conclusions regarding its long-term, residual effects post-intervention. Consequently, it remains unclear whether the benefits of Pilates can be sustained once the structured training stops. Therefore, this study aimed to investigate the efficacy of Pilates on core stability and physical fitness among sedentary individuals, providing insights into sustainable exercise interventions.

02

Conditions studied

  • Sedentary Behaviors
  • Core Muscle Weakness

Browse trials for

Keywords

  • core muscle
  • core stability
  • physical inactivity
  • pilates
  • sedentary behaviors
03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's planned enrollment of 34 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

Mahidol University is the lead sponsor of 747 studies on the registry; 119 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18 and 59 years.
  • Had a (BMI) of ≥ 23 kg/m2.
  • Engaged in sedentary activities (sitting) for more than 7 hours per day.
  • Passed the Physical Activity Readiness Questionnaire (PAR-Q) assessment.
  • Did not currently participate in any other exercise programs or physical activities during the study period.

Exclusion criteria

Exclusion Criteria:

  • Had visual impairments that could not be corrected with corrective lenses or glasses.
  • Had a medical history of spinal or lower extremity surgery.
  • Had medical conditions or received medications that affected balance and gait, such as neurological diseases or benign paroxysmal positional vertigo (BPPV).
  • Pregnant during the study period.
  • Had severe pain in any part of the body (pain score ≥ 7/10).
  • Inability to follow the research procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Participants in the experimental group participated in a Pilates exercise program.

    Other: Pilates exercise

  • Active comparator
    Control group

    Participants in the control group participated in a walking exercise program.

    Other: Walking exercise

Interventions

  • OtherPilates exercise

    The 1-hour Pilates exercise program was supervised by an instructor.

  • OtherWalking exercise

    The 1-hour walking exercise program was supervised by a physical therapist. Participants walked on a treadmill, where the speed was gradually increased to achieve a moderate intensity level, maintaining their heart rates within 64% to 70% of their maximum heart rate.

06

What researchers measure

Primary outcomes

  1. Muscle thickness

    A handheld ultrasound device was used to measure trunk muscle thickness at rest and during contraction.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

  2. Muscle strength

    A handheld dynamometer was used to measure trunk muscle strength. Participants were instructed to maintain a maximal voluntary contraction (MVC) for 5 seconds per trial, with a 30-second rest period between trials to minimize fatigue.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

  3. Muscle flexibility

    The sit-and-reach test was used to measure lower back and hamstring flexibility. Participants completed static stretching for 5 minutes before assessment. During the assessment, participants sat with knees fully extended and feet hip-width apart against the sit-and-reach box. They then reached forward, using their fingertips to displace the sliding scale as far as possible in a single trial.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

  4. Muscle endurance

    The McGill Core Endurance Test was used to measure trunk muscle endurance. Each test was conducted once, with the duration recorded using a digital stopwatch. Timing commenced once the participant achieved the standardized starting position and ceased when they could no longer maintain the required posture.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

  5. Proprioception

    Joint Repositioning Error (JRE) was measured under both eyes-open and eyes-closed conditions to assess proprioception. Participants began the assessment seated with their hips and knees flexed at 90°, feet positioned shoulder-width apart, and arms resting naturally at their sides. From this baseline, they were guided into a neutral reference position-defined by full trunk extension and a flat spinal alignment-which they were instructed to memorize. To facilitate measurement, a marker was placed at the first sacral vertebra (S1), and a laser pointer was fixed 50 cm away from this landmark. The testing procedure required participants to perform three cycles of trunk flexion and extension before attempting to return to the neutral reference position as accurately as possible. The JRE represented the distance between the laser beam's initial and final positions.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

  6. Balance

    The Y-Balance Test (YBT) was used to measure dynamic balance. Participants were instructed to reach out and push the indicator as far as possible.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

Secondary outcomes

  1. Posture

    Posture was measured using the Posture-analyzing and Virtual Reconstructing (PAViR) system, which utilized an RGB-D camera for skeletal reconstruction.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

  2. Pain level

    Pain location was identified through participant interviews, while pain intensity was quantified using a 0-10 Visual Analogue Scale (VAS).

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

  3. Health-Related Quality of Life

    Health-Related Quality of Life was measured using the Thai version of the World Health Organization Quality of Life Brief (WHOQOL-BREF-THAI). This 26-item instrument assessed four core domains: physical health, psychological health, social relationships, and environment. Responses were scored on a Likert scale, with higher scores indicating better health status and overall QoL.

    Time frame: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Research data will be shared in a de-identified format only; for instance, participant names will be replaced with codes, and faces will be blurred in all images.

Supporting information: Clinical study report

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Aug 2027, 12 months later.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 12 months is below that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2026
First posted
Jun 24, 2026
StartEst.
Aug 2026
Primary completionEst.
Aug 2027
CompletionEst.
Dec 2027
Last update
Jun 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07666919
Lead sponsor
Mahidol University
Responsible party
Rommanee Rojasavastera (Principal Investigator, Mahidol University) — Principal investigator
First posted
Jun 24, 2026
Start date
Aug 2026 (estimated)
Primary completion
Aug 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Jun 26, 2026

Study contacts

Rommanee Rojasavastera, M.Sc.
Contact
rommanee.roj@mahidol.ac.th
+66837830777

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion